NATIONAL HEALTH INVESTORS INC

NHI

CIK 0000877860 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$106M
↑+23.4% +$20Mvs FY2024 (Q4)
Operating Income
$106M
↑+57.8% +$39Mvs FY2024 (Q4)
Net Income
$38M
↓-11.7% -$5Mvs FY2024 (Q4)
Gross Profit
$106M
↑+23.4% +$20Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Weak
32/100
  • Profitability
    44ROIC 13.7% (10% = solid, 20%+ = moat)
  • Liquidity
    0Insufficient data
  • Leverage
    53D/E 0.94 (under 0.5 = conservative)
  • Efficiency
    0Asset Turnover 0.14x (1.0+ = capital-efficient)
  • Growth
    95Revenue YoY +23.4% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Insufficient data

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$300M
investment in PP&E
Dividends paid (TTM)
$170M
cash returned to holders
Stock buybacks (TTM)
share count reduction
Stock-based comp (TTM)
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$2.80B
everything owned
Total liabilities
$1.26B
everything owed
Stockholders' equity
$1.52B
shareholder claim
Net debt
$1.11B
LT debt minus cash

Recent performance · 67 quarters

Revenue↑+23.4% +$20M
$106M
Net Income↓-11.7% -$5M
$38M
Free Cash Flow↓-70.2% -$53M
$-129M
Operating Margin↓-2.4pts
52.3%

Drill down